Omada Health, Inc. (OMDA) - What Are Investment Firms Saying About This Stock?

Omada Health logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst sentiment is broadly positive: Omada Health has a “Moderate Buy” consensus, with 11 buys, three holds and one sell among 15 analysts; the average 12-month price target is $25.92.
  • Quarterly earnings topped expectations: The company reported earnings of $0.10 per share, beating the $0.02 consensus estimate, and revenue of $91.31 million.
  • Ownership activity was mixed: Company insiders sold 79,322 shares in the last quarter, while several investment firms—including BlackRock and Jefferies—reported new positions.
  • Interested in Omada Health? Here are five stocks we like better.

Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have earned an average rating of "Moderate Buy" from the fifteen research firms that are covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year target price among brokerages that have covered the stock in the last year is $25.92.

Several research firms have recently issued reports on OMDA. Needham & Company LLC reaffirmed a "buy" rating and issued a $28.00 price target on shares of Omada Health in a research report on Friday, September 11th. BMO Capital Markets reissued an "outperform" rating and set a $24.00 price objective on shares of Omada Health in a research report on Friday, August 7th. Zacks Research cut shares of Omada Health from a "strong-buy" rating to a "hold" rating in a report on Wednesday, November 4th. Wells Fargo & Company decreased their price objective on shares of Omada Health from $22.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday, November 6th. Finally, Robert W. Baird upped their price objective on Omada Health from $15.00 to $25.00 and gave the company a "neutral" rating in a research report on Wednesday, August 12th.

Read Our Latest Stock Report on Omada Health

Omada Health Stock Performance

Shares of OMDA opened at $14.49 on Friday. Omada Health has a fifty-two week low of $10.28 and a fifty-two week high of $25.45. The firm's 50-day simple moving average is $19.13 and its two-hundred day simple moving average is $17.70. The stock has a market cap of $898.96 million, a PE ratio of 70.00 and a beta of 2.13.

Omada Health (NASDAQ:OMDA - Get Free Report) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.10 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.08. Omada Health had a return on equity of 5.71% and a net margin of 4.21%. The company had revenue of $91.31 million during the quarter. Equities research analysts predict that Omada Health will post 0.09 EPS for the current year.

Insiders Place Their Bets

In other news, CFO Steven Cook sold 6,800 shares of the business's stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.86, for a total value of $148,648.00. Following the completion of the transaction, the chief financial officer owned 173,906 shares in the company, valued at $3,801,585.16. The trade was a 3.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Sean Duffy sold 12,944 shares of the company's stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $19.22, for a total value of $248,783.68. Following the transaction, the chief executive officer directly owned 382,594 shares in the company, valued at approximately $7,353,456.68. The trade was a 3.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 79,322 shares of company stock valued at $1,720,914. Corporate insiders own 6.38% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Omada Health in the second quarter worth about $48,775,000. Marshall Wace LLP raised its stake in Omada Health by 790.1% during the 3rd quarter. Marshall Wace LLP now owns 920,258 shares of the company's stock valued at $19,151,000 after purchasing an additional 816,871 shares during the period. Jefferies Financial Group Inc. purchased a new position in Omada Health in the 2nd quarter worth approximately $15,016,000. Madryn Asset Management LP purchased a new stake in Omada Health during the 2nd quarter valued at approximately $12,814,410. Finally, Walleye Capital LLC purchased a new stake in Omada Health during the 2nd quarter valued at approximately $11,648,000.

Omada Health Company Profile

(Get Free Report)

Omada Health is a U.S. digital health company that provides virtual care programs for people managing chronic conditions. Its services address areas including diabetes, prediabetes, hypertension, musculoskeletal conditions and weight management. The company combines digital tools, personalized health coaching and, where appropriate, clinical support to help members build health habits and manage their care. Programs may include mobile-app-based guidance and connected devices, such as scales or blood pressure monitors.

Recommended Stories

Analyst Recommendations for Omada Health (NASDAQ:OMDA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Omada Health Right Now?

Before you consider Omada Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.

While Omada Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines